164 related articles for article (PubMed ID: 28358132)
1. Ultrasensitive detection of TCR hypervariable-region sequences in solid-tissue RNA-seq data.
Li B; Li T; Wang B; Dou R; Zhang J; Liu JS; Liu XS
Nat Genet; 2017 Mar; 49(4):482-483. PubMed ID: 28358132
[No Abstract] [Full Text] [Related]
2. Rules of Engagement: The Lymphocyte Receptor Ecosystem in Renal Cell Carcinoma.
Krishna C; Hakimi AA
Cancer Res; 2022 Mar; 82(5):764-765. PubMed ID: 35247895
[TBL] [Abstract][Full Text] [Related]
3. Dominant rearrangements among human tumor-infiltrating lymphocytes. Analysis of T-cells derived from 32 patients with melanoma, lung, and renal cell carcinoma.
Bennett WT; Pandolfi F; Grove BH; Hawes GE; Boyle LA; Kradin RL; Kurnick JT
Cancer; 1992 May; 69(9):2379-84. PubMed ID: 1314129
[TBL] [Abstract][Full Text] [Related]
4. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas.
Zhang Q; Jia Q; Deng T; Song B; Li L
Biochem Biophys Res Commun; 2015 Feb; 458(1):70-6. PubMed ID: 25637538
[TBL] [Abstract][Full Text] [Related]
6. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
Jantzer P; Schendel DJ
Cancer Res; 1998 Jul; 58(14):3078-86. PubMed ID: 9679974
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes.
Riccobon A; Gunelli R; Ridolfi R; De Paola F; Flamini E; Fiori M; Saltutti C; Petrini M; Fiammenghi L; Stefanelli M; Granato AM; Cuzzocrea DE; Amadori D
Cancer Invest; 2004; 22(6):871-7. PubMed ID: 15641485
[TBL] [Abstract][Full Text] [Related]
8. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
Ikeda H; Sato N; Matsuura A; Kikuchi K
Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
[TBL] [Abstract][Full Text] [Related]
9. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
[TBL] [Abstract][Full Text] [Related]
10. Antigen Receptor Sequence Reconstruction and Clonality Inference from scRNA-Seq Data.
Lindeman I; Stubbington MJT
Methods Mol Biol; 2019; 1935():223-249. PubMed ID: 30758830
[TBL] [Abstract][Full Text] [Related]
11. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
Li P; Conley A; Zhang H; Kim HL
BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
[TBL] [Abstract][Full Text] [Related]
12. SCINA: A Semi-Supervised Subtyping Algorithm of Single Cells and Bulk Samples.
Zhang Z; Luo D; Zhong X; Choi JH; Ma Y; Wang S; Mahrt E; Guo W; Stawiski EW; Modrusan Z; Seshagiri S; Kapur P; Hon GC; Brugarolas J; Wang T
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31336988
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
14. Tissue Micro Arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma.
Scognamiglio G; Cantile M; Scala S; Cecere S; Russo F; Collina F; Marra L; Sabbatino F; Botti G; Franco R
Int J Clin Exp Pathol; 2014; 7(4):1814-8. PubMed ID: 24817986
[No Abstract] [Full Text] [Related]
15. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
[TBL] [Abstract][Full Text] [Related]
16. T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor.
Kudoh S; Stanley J; Edinger MG; Tubbs RR; Klein E; Bukowski RM; Finke JH
Int J Cancer; 1994 Aug; 58(3):369-75. PubMed ID: 8050820
[TBL] [Abstract][Full Text] [Related]
17. Immunoscoring by correlating MHC class II and TCR expression: high level immune functions represented by the KIRP dataset of TCGA.
Butler SN; Blanck G
Cell Tissue Res; 2016 Feb; 363(2):491-6. PubMed ID: 26293619
[TBL] [Abstract][Full Text] [Related]
18. pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma.
Ruf M; Mittmann C; Nowicka AM; Hartmann A; Hermanns T; Poyet C; van den Broek M; Sulser T; Moch H; Schraml P
Clin Cancer Res; 2015 Feb; 21(4):889-98. PubMed ID: 25691774
[TBL] [Abstract][Full Text] [Related]
19. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
